US equities |
NVDA $204.64 ▼-4.22% INTC $65.76 ▼-28.58% MU $884.74 ▼-5.30% AMZN $240.35 ▼-1.41% AAPL $344.63 ▼-1.23% SNDK $1,150.89 ▼-13.47% AMD $504.80 ▼-10.88% MSFT $521.91 ▼-1.55%
FinancialContent

Latest News about Reunion Neuroscience Inc/

Recent news which mentions Reunion Neuroscience Inc/

Hope For Postpartum Depression: This Company To Launch Clinical Trial On Next-Gen Psychedelic
Tickers MSSTF
Tags Management Cannabis Next/Generation Psychedelics
From Benzinga
Former Field Trip Health, Now Reunion Neuroscience: Q1 2023 Financial Results & Corporate Reorganization
Tags Legal Psychedelics Markets
From Benzinga
Field Trip's Phase I Clinical Study Of Psilocybin Analog FT-104 Begins Dosing In Australia
Tags News Market News Psychedelics
From Benzinga
Field Trip Health To Divide Into Two Separate Public Companies
Tickers FTRP
Tags Reunion Neuroscience Inc/ Cannabis Benzinga
From Benzinga